Results 111 to 120 of about 56,319 (181)

YAP Inhibits HIV-1 transcription and promotes HIV-1 latency by regulating E3 ubiquitin ligase UHRF1 mediated tat degradation. [PDF]

PLoS Pathog
Zhou C, He H, Zhang Y, Liu X, Xia M, Qiu J, Wu Z, Rashid HK, Liu W, Peng J, Li L.   +10 more
europepmc   +1 more source

Upstream Stimulatory Factors Regulate HIV-1 Latency and Are Required for Robust T Cell Activation. [PDF]

Viruses, 2023
Horvath RM, Sadowski I.
europepmc   +1 more source

Ethnopharmacological exploration and isolation of HIV-1 latency-reversing agents from Sudanese medicinal plants. [PDF]

Front Pharmacol
Elamin KM, Kishimoto N, Kawahara T, Idris Elbashir SM, Yasutake T, Wada M, Hitora Y, Kordofani M, Osman W, Elbashir MI, Misumi S.   +10 more
europepmc   +1 more source

New insights into transcription elongation control of HIV-1 latency and rebound. [PDF]

Trends Immunol, 2023
Mbonye U, Kizito F, Karn J.
europepmc   +1 more source

Epigenetic silencing by the SMC5/6 complex mediates HIV-1 latency. [PDF]

Nat Microbiol, 2022
Irwan ID, Bogerd HP, Cullen BR.
europepmc   +1 more source

A targeted CRISPR screen identifies ETS1 as a regulator of HIV-1 latency. [PDF]

PLoS Pathog
Ashokkumar M, Hafer TL, Felton A, Archin NM, Margolis DM, Emerman M, Browne EP.   +6 more
europepmc   +1 more source

Impact of chromatin on HIV-1 latency: a multi-dimensional perspective. [PDF]

Epigenetics Chromatin
Jones JE, Gunderson CE, Wigdahl B, Nonnemacher MR.   +3 more
europepmc   +1 more source

The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy. [PDF]

Sci Adv, 2023
Prins HAB, Crespo R, Lungu C, Rao S, Li L, Overmars RJ, Papageorgiou G, Mueller YM, Stoszko M, Hossain T, Kan TW, Rijnders BJA, Bax HI, van Gorp ECM, Nouwen JL, de Vries-Sluijs TEMS, Schurink CAM, de Mendonça Melo M, van Nood E, Colbers A, Burger D, Palstra RJ, van Kampen JJA, van de Vijver DAMC, Mesplède T, Katsikis PD, Gruters RA, Koch BCP, Verbon A, Mahmoudi T, Rokx C.   +30 more
europepmc   +1 more source

On HIV-1 latency and viral reservoirs

, 2015
HIV-1 establishes a latent infection that is inaccessible to treatment in cellular and anatomical reservoirs. This thesis concerns several problematic issues of HIV-1 persistence, including ways to measure and monitor both the virus at low viral concentrations and the depletion of the reservoir.
openaire  

Traditional Medicine Extracts of <i>Gnidia sericocephala</i> and Product Nkabinde in HIV-1 Latency Reversal: Insights from J-Lat Subtype B and J-Lat Subtype C Models. [PDF]

Int J Mol Sci
Mngomezulu K, Khathi SP, Nkabinde SA, Nkabinde M, Ngcobo M, Gqaleni N.   +5 more
europepmc   +1 more source